Natural history of adult-onset Ménétrier's disease: Report of a case with 9-year follow-up.

Ménétrier's disease (MD) is a rare disease characterized by markedly hypertrophied gastric mucosal folds typically associated with hypoalbuminemia and anemia. However, the natural history of MD in adults remains unclear and is rarely reported in the literature. The current study presents a case of MD with a 9-year follow-up. A 56-year-old man was diagnosed with MD in 2005. The patient was followed up and underwent surveillance endoscopy once or twice each year. In the present case, the anemia and hypoproteinemia were eliminated following red blood cell transfusion and intravenous iron therapies. The symptoms were relieved after 4 years. Treatment with octreotide had little effect on the gastric mucosa, while antimicrobial combination therapy provided no benefit in the present H. pylori-negative case of MD. In addition, despite abnormalities of the gastric mucosa in the patient persisting after 9 years of follow-up with no evidence of malignancy, malignant transformation in MD should not be overlooked, and regular monitoring of the gastric mucosa via endoscopy is necessary.

[1]  R. Coffey,et al.  Pierre Ménétrier and his disease. , 2012, Transactions of the American Clinical and Climatological Association.

[2]  M. Washington,et al.  Distinguishing Ménétrier's disease from its mimics , 2010, Gut.

[3]  R. Pai,et al.  Successful Use of Octreotide to Treat Ménétrier’s Disease: A Rare Cause of Abdominal Pain, Weight Loss, Edema, and Hypoalbuminemia , 2009, Digestive Diseases and Sciences.

[4]  U. Kumar,et al.  Somatostatin receptors 1 and 5 heterodimerize with epidermal growth factor receptor: agonist-dependent modulation of the downstream MAPK signalling pathway in breast cancer cells. , 2009, Cellular signalling.

[5]  Young Sook Park,et al.  Ménétrier's disease associated with herpes infection: response to treatment with acyclovir. , 2007, Gastrointestinal endoscopy.

[6]  J. M. Ramia,et al.  Enfermedad de Ménétrier y cáncer gástrico , 2007 .

[7]  Y. Mok,et al.  Primary Squamous Cell Carcinoma of the Stomach That Developed with Menetrier's Disease , 2007, Digestive Diseases and Sciences.

[8]  O. Hosokawa,et al.  Remission of severe anemia persisting for over 20 years after eradication of Helicobacter pylori in cases of Ménètrier's disease and atrophic gastritis: Helicobacter pylori as a pathogenic factor in iron-deficiency anemia. , 2003, Internal medicine.

[9]  G. Montalto,et al.  Resolution of Ménétrier’s Disease after Helicobacter pylori Eradicating Therapy , 2001, Digestive Diseases.

[10]  K. Washington,et al.  Treatment of Ménétrier's disease with a monoclonal antibody against the epidermal growth factor receptor. , 2000, The New England journal of medicine.

[11]  F. Wrba,et al.  Successful Symptomatic Management of a Patient with Ménétrier’s Disease with Long-Term Antibiotic Treatment , 1999, Digestion.

[12]  T. Akamatsu,et al.  Remission of Ménétrier's disease after a prolonged period with therapeutic eradication of Helicobacter pylori. , 1999, The American journal of gastroenterology.

[13]  T. Akamatsu,et al.  Remission of Méneétrier's disease after a prolonged period with therapeutic eradication of Helicobacter pylori , 1999, American Journal of Gastroenterology.

[14]  J. Lambert,et al.  Helicobacter pylori as a pathogenic factor in Ménétrier's disease , 1998, American Journal of Gastroenterology.

[15]  P. Rutgeerts,et al.  Hypertrophic lymphocytic gastritis with a gastric carcinoma. , 1998, European journal of gastroenterology & hepatology.

[16]  M. Fujishima,et al.  Ménétrièr's disease associated with Helicobacter pylori infection: resolution of enlarged gastric folds and hypoproteinemia after antibacterial treatment. , 1997, The American journal of gastroenterology.

[17]  A. Griffiths,et al.  Acute cytomegalovirus infection in a child with Ménétrier's disease. , 1995, Gastroenterology.

[18]  A. Schally,et al.  Somatostatin analog RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of androgen-independent DU-145 human prostate cancer line in nude mice. , 1993, Cancer letters.

[19]  M. Stolte,et al.  Ménétrier's disease and Helicobacter pylori. , 1993, The New England journal of medicine.

[20]  H. Frierson,et al.  Octreotide reduces enteral protein losses in Ménétrier's disease. , 1993, The American journal of gastroenterology.

[21]  R. Coffey,et al.  Possible role of transforming growth factor alpha in the pathogenesis of Ménétrier's disease: supportive evidence form humans and transgenic mice. , 1992, Gastroenterology.

[22]  B. Gayet,et al.  Hypertrophic gastropathy with gastric adenocarcinoma: Menetrier's disease and lymphocytic gastritis? , 1991, Gut.

[23]  G. Tonietto,et al.  [Ménètrier's disease and gastric cancer]. , 1987, Minerva chirurgica.

[24]  R. Brown,et al.  Intramucosal carcinoma of the gastric antrum complicating Menetrier's disease. , 1983, Journal of clinical pathology.

[25]  B. Scharschmidt.  The natural history of hypertrophic gastrophy (Menetrier's disease). Report of a case with 16 year follow-up and review of 120 cases from the literature. , 1977, The American journal of medicine.

[26]  B. Corrin,et al.  Diffuse hypertrophy of gastric mucosa (Menétrier's disease) and iron-deficiency anaemia , 1969, Gut.